On-site, high-fidelity target sequencing and absolute quantitation for HIV-1 surveillance
By leighsilverstein|2023-01-11T14:40:13-05:00May 25, 2022|Clinical Sequencing, Sequencing Technology Development|0 Comments
About the Author: leighsilverstein
A freelance website developer and soon to be mom to a beautiful daughter. Wife to a wonderful and loving husband, Cord. Mom to a bouncing puppy named Chance.
METHYL-SENTRY: Proposed feasibility study of a nanopore diagnostic tool with rapid automated measurement of cell free DNA methylation state for clinical cancer evaluation
Leave a Reply